Related Experiment Video

Updated: Jun 1, 2026

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Evidence-based treatment of carotid artery stenosis

Kate C Young1, Anunaya Jain, Minal Jain

  • 1Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA.

Neurosurgical Focus
|June 3, 2011
PubMed

Insights

Carotid endarterectomy (CEA) effectively reduces stroke risk for symptomatic stenosis. Carotid angioplasty and stenting (CAS) is an alternative, but current evidence suggests it should be reserved for specific cases.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiovascular Medicine

Background:

  • Carotid atheromatous disease is a significant risk factor for stroke.
  • Carotid endarterectomy (CEA) is a proven intervention for symptomatic carotid stenosis (>50%).
  • Carotid angioplasty and stenting (CAS) is a newer alternative revascularization technique.

Purpose of the Study:

  • To review randomized trials comparing CEA and CAS for stroke prevention.
  • To analyze trial design and results in symptomatic and asymptomatic carotid stenosis.
  • To discuss the evolving role of medical management and revascularization techniques.

Main Methods:

  • Review of randomized controlled trials (RCTs) and population-based studies.
  • Analysis of trial outcomes based on patient symptom status (symptomatic vs. asymptomatic).
  • Evaluation of perioperative risk and patient life expectancy in treatment decisions.

Main Results:

  • CEA demonstrates superiority over best medical management for symptomatic stenosis.
  • Studies comparing CEA and CAS show varying results, necessitating careful trial design analysis.
  • Improvements in best medical management may be reducing stroke risk in asymptomatic stenosis.

Conclusions:

  • CEA remains a primary treatment for symptomatic carotid stenosis.
  • CAS should be limited to specific indications due to current evidence.
  • The choice of revascularization depends on symptom status and individual patient factors.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...